Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance...

Area of Science:

• Biomedical Engineering
• Oncology
• Analytical Chemistry

Background:

• Predicting cancer drug response requires rapid assessment of cell surface markers.
• Activated matriptase is a promising target for selective cancer therapies.
• Existing detection methods may not be suitable for point-of-care applications.

Purpose of the Study:

• To develop a novel technique for electrical detection of proteins on cancer cell surfaces.
• To implement multi-frequency microfluidic impedance cytometry for biosensing.
• To demonstrate proof-of-concept for detecting activated matriptase on cancer cells.

Main Methods:

• Utilized a biosensor with gold microelectrodes in a microfluidic channel.
• Integrated immuno-magnetic separation for cancer cell isolation.
• Employed multi-frequency impedance cytometry to differentiate cell types and aggregates.

Main Results:

• Successfully differentiated between bare magnetic beads, cancer cells, and bead-cell aggregates.
• Demonstrated the capability to detect activated matriptase proteins on cultured Mantle cells.
• Established proof-of-concept for the electrical detection technique.

Conclusions:

• The developed microfluidic impedance cytometry biosensor shows promise for rapid, point-of-care detection of cancer biomarkers.
• This technology could facilitate personalized cancer treatment strategies.
• Further research can explore broader applications in cancer diagnostics and therapeutics.